Pachyonychia Congenita
- Keratin 6A, 6B, 6C, 16, 17 gene mutations
- Autosomal dominant inheritance
- Type 1 (Jadassohn–Lewandowsky) due to keratin 6a / 16 gene mutation leads to severe palmoplantar keratoderma and oral leukokeratosis
- Type 2 (Jackson–Lawler) due to keratin 6b / 17 gene mutation leads to pilosebaceous cysts, neonatal teeth
- Current classification system of paronychia congenita: -6a (~40%), -6b (~5–10%), -6c (<5%), -16 (~30%), -17 (~15–20%)
- Ectodermal (nail bed, palmoplantar skin, pilosebaceous unit, oral mucosa, tooth) anomalies
- Toenail dystrophy, focal keratoderma, plantar pain
- Keratin 6a gene mutation causes oral mucosa and nail disease
- Keratin 17 gene mutation causes pilosebaceous unit disease, steatocystoma multiplex
- Keratin 6c / 16 causes focal palmoplantar keratoderma
- Wedge-shaped subungual hyperkeratosis (“omega” shape), fissures, frictional blisters, palmoplantar hyperhidrosis, paronychia, severe pain, follicular keratoses, angular cheilitis, oral leukokeratosis, natal teeth, hair abnormalities, steatocystomas, vellus hair cysts, hoarseness, respiratory tract obstruction
Pathology:
- Cytoplasmic pallor and eosinophilic inclusions among superficial epidermal keratinocytes
- Perinuclear aggregation of abnormal keratin filaments, cytoplasm vacuolization
- Similar to white sponge nevus histology (due to keratin 4, 13 gene mutations)
Differential:
- Clouston syndrome
- Keratolytic soaks with subsequent cutting and filing
- Orthotics
- Botulinum toxin type A injection for hyperhidrosis
- Oral retinoids to decrease hyperkeratosis (risk of increased pain)
- Small interfering RNAs
- Topical sirolimus
- Oral simvastatin